Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-128800 interaction study with atenolol or diltiazem in healthy volunteers
NL-OMON36345Active, not recruiting
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Mar 2011
- Modality
- Small Molecules, Molecular Glues → Targeted Protein Degraders (TPDs) → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ponesimod, atenolol and diltiazem in Immune disorder (4 arms), sponsored by Actelion Pharmaceuticals Ltd. Primary endpoints: Heart rate and rhythm by telemetry, Pharmacokinetics and 1 more. Started Mar 2011; status: active, not recruiting.
02
Drugs
ponesimodatenololdiltiazem
03
Conditions
Immune disorder
Beyond the preview
Go deeper on NL-OMON36345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36345.